Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10520-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10520-1-AP, RRID:AB_2057977
- Product name
- APOD antibody
- Antibody type
- Polyclonal
- Description
- APOD antibody (Cat. #10520-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Uncovering the potential of APOD as a biomarker in gastric cancer: A retrospective and multi-center study.
A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
Integration of transcriptome and proteome profiles in placenta accreta reveals trophoblast over-migration as the underlying pathogenesis.
Apolipoprotein D: a potential biomarker for cerebral amyloid angiopathy.
Apolipoprotein D as a novel marker in human end-stage heart failure: a preliminary study.
Wang Z, Chen H, Sun L, Wang X, Xu Y, Tian S, Liu X
Computational and structural biotechnology journal 2024 Dec;23:1051-1064
Computational and structural biotechnology journal 2024 Dec;23:1051-1064
A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
Khan M, Lin J, Wang B, Chen C, Huang Z, Tian Y, Yuan Y, Bu J
Frontiers in immunology 2022;13:968165
Frontiers in immunology 2022;13:968165
Integration of transcriptome and proteome profiles in placenta accreta reveals trophoblast over-migration as the underlying pathogenesis.
Li N, Hou R, Liu C, Yang T, Qiao C, Wei J
Clinical proteomics 2021 Dec 29;18(1):31
Clinical proteomics 2021 Dec 29;18(1):31
Apolipoprotein D: a potential biomarker for cerebral amyloid angiopathy.
Kuiperij HB, Hondius DC, Kersten I, Versleijen AAM, Rozemuller AJM, Greenberg SM, Schreuder FHBM, Klijn CJM, Verbeek MM
Neuropathology and applied neurobiology 2020 Aug;46(5):431-440
Neuropathology and applied neurobiology 2020 Aug;46(5):431-440
Apolipoprotein D as a novel marker in human end-stage heart failure: a preliminary study.
Wei YJ, Huang YX, Zhang XL, Li J, Huang J, Zhang H, Hu SS
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2008 Aug;13(5):535-48
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2008 Aug;13(5):535-48
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human serum tissue were subjected to SDS PAGE followed by western blot with 10520-1-AP(APOD antibody) at dilution of 1:1000
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The APOD antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human APOD. This antibody recognizes human antigen. The APOD antibody has been validated for the following applications: ELISA, WB, IHC analysis.
